Canada needs to ‘amp it up’ in wake of competitive U.S. and Chinese pharma policies, says Innovative Medicines Canada CEO
‘Where is R&D flourishing right now? It’s not in the U.S. It’s not in Europe. It’s in China,’ says IMC’s Bettina Hamelin at Canada’s Drug Agency’s annual symposium.


